Showing results (191-200 of 217) with videos related to

Sort By:
Pageof 22
Cell Transplantation|July 1, 2010
Isolation and propagation of a human CD133(-) colon tumor-derived cell line with tumorigenic and angiogenic propertiesNalú Navarro-Alvarez, Eisaku Kondo, Hironobu Kawamoto, et al.
Transplantation|August 12, 2009
Bone repair by transplantation of hTERT-immortalized human mesenchymal stem cells in miceHiroyuki Nakahara, Haruo Misawa, Takahiro Hayashi, et al.
Clinical Genitourinary Cancer|April 17, 2021
Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world StudyJ Connor Wells, Shaan Dudani, Chun Loo Gan, et al.
Cancer|October 12, 2018
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumSteven M Yip, Connor Wells, Raphael Moreira, et al.
European Urology|August 26, 2019
First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database ConsortiumShaan Dudani, Jeffrey Graham, J Connor Wells, et al.
JAMA Network Open|January 21, 2021
Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With SurvivalShaan Dudani, Guillermo de Velasco, J Connor Wells, et al.
European Urology|October 25, 2016
Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic CategoryIan D Davis, Wanling Xie, Carmel Pezaro, et al.
European Urology|May 5, 2020
Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell CarcinomaBimal Bhindi, Jeffrey Graham, J Connor Wells, et al.
European Urology Oncology|January 1, 2025
Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium AnalysisMehul Gupta, Connor Wells, Meredith M Regan, et al.
European Urology Oncology|November 1, 2023
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumKosuke Takemura, Matthew S Ernst, Vishal Navani, et al.
Pageof 22